Vanguard Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238M | Buy |
|
|||||
|
2025
Q1 | $216M | Sell |
|
|||||
|
2024
Q4 | $223M | Buy |
|
|||||
|
2024
Q3 | $197M | Buy |
|
|||||
|
2024
Q2 | $162M | Buy |
|
|||||
|
2024
Q1 | $138M | Buy |
|
|||||
|
2023
Q4 | $134M | Buy |
|
|||||
|
2023
Q3 | $111M | Sell |
|
|||||
|
2023
Q2 | $134M | Sell |
|
|||||
|
2023
Q1 | $137M | Buy |
|
|||||
|
2022
Q4 | $123M | Sell |
|
|||||
|
2022
Q3 | $154M | Buy |
|
|||||
|
2022
Q2 | $158M | Buy |
|
|||||
|
2022
Q1 | $194M | Buy |
|
|||||
|
2021
Q4 | $265M | Sell |
|
|||||
|
2021
Q3 | $240M | Buy |
|
|||||
|
2021
Q2 | $200M | Buy |
|
|||||
|
2021
Q1 | $231M | Buy |
|
|||||
|
2020
Q4 | $145M | Buy |
|
|||||
|
2020
Q3 | $136M | Sell |
|
|||||
|
2020
Q2 | $166M | Sell |
|
|||||
|
2020
Q1 | $116M | Buy |
|
|||||
|
2019
Q4 | $164M | Sell |
|
|||||
|
2019
Q3 | $163M | Sell |
|
|||||
|
2019
Q2 | $195M | Sell |
|
|||||
|
2019
Q1 | $243M | Buy |
|
|||||
|
2018
Q4 | $262M | Sell |
|
|||||
|
2018
Q3 | $574M | Buy |
|
|||||
|
2018
Q2 | $419M | Buy |
|
|||||
|
2018
Q1 | $321M | Buy |
|
|||||
|
2017
Q4 | $253M | Buy |
|
|||||
|
2017
Q3 | $241M | Buy |
|
|||||
|
2017
Q2 | $211M | Buy |
|
|||||
|
2017
Q1 | $179M | Buy |
|
|||||
|
2016
Q4 | $164M | Buy |
|
|||||
|
2016
Q3 | $159M | Buy |
|
|||||
|
2016
Q2 | $181M | Buy |
|
|||||
|
2016
Q1 | $150M | Buy |
|
|||||
|
2015
Q4 | $146M | Buy |
|
|||||
|
2015
Q3 | $114M | Buy |
|
|||||
|
2015
Q2 | $132M | Buy |
|
|||||
|
2015
Q1 | $78.4M | Buy |
|
|||||
|
2014
Q4 | $53.1M | Buy |
|
|||||
|
2014
Q3 | $43.2M | Sell |
|
|||||
|
2014
Q2 | $65M | Buy |
|
|||||
|
2014
Q1 | $66.2M | Buy |
|
|||||
|
2013
Q4 | $35.8M | Buy |
|
|||||
|
2013
Q3 | $23.9M | Buy |
|
|||||
|
2013
Q2 | $20.3M | Buy |
|